Avacta Group PLC banner

Intrinsic Value

The intrinsic value of Avacta Group PLC (RTQ1) under the Base Case is 0.013 EUR per share. Compared with the current market price of 0.795 EUR, the stock appears Overvalued by 98% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

RTQ1 Intrinsic Value
€0.013
Overvaluation 98%
Intrinsic Value
Price €0.795

RTQ1 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor RTQ1
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.01
Get notified when the price drops into your buy zone
Current Price €0.8
Intrinsic Value €0.01
Margin of Safety 20% €0.01
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RTQ1

Fundamental Analysis

What Avacta Group Does

Biotechnology Health Care

Avacta Group is a life sciences company built around its proprietary Affimer technology, which creates small binding proteins used in diagnostics and drug development. In simple terms, it makes tools that can recognize specific biological targets and then sells or licenses those tools for research, testing, and therapeutic work.

Headquarters
United Kingdom UK
Employees
151
IPO date
Sep 8, 2003
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Avacta Group PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RTQ1 stock?

The intrinsic value for Avacta Group PLC (RTQ1) under the Base Case is 0.013 EUR.

Is RTQ1 stock undervalued or overvalued?

Compared with the current market price of 0.795 EUR, the stock appears Overvalued by 98% .

Back to Top